Jetema Signs ₩40.2B Exclusive Supply Contract for Botox and Fillers
High impactPredicted impact: High· Actual: −9.7% vs sector, volume 0.6× normal (5 trading days)
Supply contract worth about 52% of last year's revenue, far above the 10% threshold.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.